|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008963213 |
| 003 |
SK-MaSNL |
| 005 |
20260303070744.0 |
| 008 |
140303c2007 xo wrzp 0 0slo |
| 015 |
|
|
|a SNBRB2007/04
|2 snkbucl
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.921.5-085
|2 1997
|
| 080 |
|
|
|a 615.281
|2 1997
|
| 245 |
0 |
0 |
|a Medikamentózna liečba chrípkových ochorení - mýty a fakty
|c [spracoval] (jen)
|
| 300 |
|
|
|a Fotogr.
|
| 500 |
|
|
|a Prevzaté: (Ars Medici 1/2007)
|
| 650 |
0 |
7 |
|a chrípka
|x farmakoterapia
|2 snkbucl
|9 866891
|
| 650 |
0 |
7 |
|a inhibítory neuraminidázy
|2 snkbucl
|9 1068604
|
| 650 |
0 |
7 |
|a amantadín
|2 snkbucl
|9 1068605
|
| 650 |
0 |
7 |
|a rimantadín
|2 snkbucl
|9 1068606
|
| 650 |
0 |
7 |
|a zanamivir
|2 snkbucl
|9 909024
|
| 650 |
0 |
7 |
|a oseltamivir
|2 snkbucl
|9 866892
|
| 650 |
0 |
7 |
|a antivirotiká
|2 snkbucl
|9 19249
|
| 773 |
0 |
|
|t Zdravotnícke noviny
|g Roč. XII, č. 13 (2007)
|x 1335-4477
|
| 773 |
0 |
|
|t Lekárske listy
|g Č. 13 (2007), s. 11
|
| 852 |
|
|
|a SNK
|b KIS3GCP
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a SK
|
| 999 |
|
|
|c 1756781
|d 1758711
|
